Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Draft US House bill sets up a host of new clinical trial provisions

With the aim of getting new drugs to patients more quickly, a new House draft bill released Wednesday offers a whole set of new ideas around what the NIH and FDA can do to speed drug discovery and development.

News in brief

WuXi begins construction on $150m disposable biomanufacturing site in China

WuXi PharmaTech subsidiary WuXi Biologics has begun construction on a new $150m biologics manufacturing facility in Wuxi, China, which is expected to be the largest mammalian cell culture manufacturing sire using disposable bioreactors in the world.

Roundup of CRO partnerships, offerings and other news

A number of small, mid-sized and large CROs (contract research organizations) and other companies tied to the world of clinical research have announced various partnerships and other financial moves over the past week. Here’s a roundup of the latest:

Parexel sees modest quarterly growth as backlog rises by nearly $1bn

Although Parexel’s consolidated service revenue increased by only 2% for the quarter, the company reported that its backlog included gross new business wins of $942.4m, which was 5.3% higher than the same quarter as last year.

News in brief

Charles River stock falls nearly 10% on soft quarterly results

Charles River Laboratories saw only slight growth in revenue compared to the same quarter last year, which was driven by its safety assessment and endotoxin and microbial detection businesses, and double-digit revenue increases from mid-tier biotech clients.

FDA’s Woodcock calls to cut clinical costs via new efficiencies

As the cost of clinical trials continues to grow, Janet Woodcock, director of the Center for Drug Evaluation and Research at the FDA told Senators earlier this week that there are “ways to greatly improve clinical trial efficiency,” and cut costs through the use of master protocols and real-world data.

Key Industry Events